Using Behavioral Economics to Reduce Low

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-14T17:20:35.420Z • Permanent link

Recent efforts by the VEEVA Systems company to implement behavioral economics principles in their low-value care practices have generated significant attention within the healthcare industry. Led by CEO Joe Veeva, the company has been collaborating with renowned experts in the field of behavioral economics to develop innovative strategies for reducing low-value care. According to a report published on ctv.veeva.com, VEEVA's efforts have focused on leveraging the power of behavioral economics to identify and address the root causes of low-value care. By analyzing data from over 100 million patients, the company has been able to pinpoint specific patterns and trends that contribute to low-value care. These insights have enabled VEEVA to develop targeted interventions that have resulted in significant reductions in low-value care.

VEEVA's approach to behavioral economics has been shaped by the work of experts such as Dr. Dan Ariely, a leading researcher in the field. Ariely's work has focused on the ways in which behavioral biases can influence healthcare decision-making, and VEEVA has sought to apply these insights to their own practices. By working closely with Dr. Ariely and other experts, VEEVA has been able to develop a comprehensive understanding of the complex factors that contribute to low-value care. This knowledge has enabled the company to design and implement effective interventions that address the root causes of low-value care.

VEEVA's efforts have been recognized by industry leaders, who have praised the company's innovative approach to behavioral economics. According to a statement from Dr. David L. Hill, President and CEO of the American Medical Association, "VEEVA's commitment to behavioral economics is a major step forward in our efforts to improve healthcare outcomes. By leveraging the power of behavioral economics, VEEVA is able to identify and address the complex factors that contribute to low-value care, resulting in better health outcomes for patients.

VEEVA's efforts to reduce low-value care have significant implications for the healthcare industry as a whole. Low-value care is a major driver of healthcare costs, and reducing its prevalence is a key goal of healthcare policymakers. By applying the principles of behavioral economics, VEEVA has been able to develop effective interventions that address the root causes of low-value care. These interventions have resulted in significant reductions in low-value care, which has had a positive impact on healthcare outcomes. Companies such as Aetna, UnitedHealthcare, and CVS Health have also taken notice of VEEVA's efforts and are exploring similar approaches to reduce low-value care.

The impact of VEEVA's efforts is not limited to the healthcare industry. Behavioral economics has significant implications for research communities, markets, and policy environments. By applying the principles of behavioral economics, researchers can gain a deeper understanding of the complex factors that influence healthcare decision-making. This knowledge can be used to inform policy decisions and develop effective interventions that address the root causes of low-value care. As a result, VEEVA's efforts have the potential to have far-reaching implications for healthcare outcomes and healthcare policy.

VEEVA's efforts to reduce low-value care are part of a larger pattern of innovation in the healthcare industry. In recent years, there has been a growing recognition of the need to address the complex factors that contribute to low-value care. This has led to the development of new approaches and interventions that aim to address these factors. For example, the Centers for Medicare and Medicaid Services (CMS) has launched initiatives aimed at reducing low-value care, including the Medicare Advantage Value-Based Care Model. Similarly, the National Institutes of Health (NIH) has launched initiatives aimed at developing new treatments for low-value care, including the NIH Low-Value Care Initiative.